Thumbay Research Institute for Precision Medicine (TRIPM)

Leading the Innovation in Precision Medicine

The Thumbay Research Institute for Precision Medicine (TRIPM) is dedicated to advancing interdisciplinary basic and translational research in cancer and diabetes, two of the most pressing healthcare challenges in the UAE. As the burden of these diseases continues to rise, TRIPM is committed to delivering innovative, patient-centered solutions through precision and personalized medicine.

The institute focuses on comprehensive translational research, with the ambition of becoming a regional centre of excellence and a leader in personalized healthcare. Its activities are centered around the development and application of state-of-the-art research platforms, including liquid biopsy, next-generation sequencing (NGS), functional genomics, advanced imaging, and gene editing technologies. These capabilities position TRIPM at the forefront of international research, particularly in the field of personalized cancer immunotherapy.

Ultimately, TRIPM aims to elevate Gulf Medical University (GMU) as a leading research institution and a national model for medical education by integrating innovation, research excellence, and clinical impact.

Relevance to the University and Hospital

TRIPM serves as a dynamic bridge connecting scientists, faculty, and clinicians, fostering a collaborative and synergistic research environment. Through a well-defined and focused research agenda, the institute promotes scientific excellence and impactful discoveries.

By providing advanced infrastructure, cutting-edge technologies, and a supportive research ecosystem, TRIPM is establishing an optimal environment for investigators and multidisciplinary teams. The institute is designed to drive innovation in cancer research and diagnostics while enabling seamless collaboration across research, education, healthcare, and industry—strengthening its role as a hub for translational impact and scientific advancement.